Verici DX reaches a global licensing and commercialisation agreement with Thermo Fisher Scientific
Agreement grants rights to further develop an assay for pre-transplant prognostic testing
20-Nov-2023 -
Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant, announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection.
The exclusive ...
assays
clinical diagnostics
diagnostics
+4